Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use

Immune thrombocytopenia (ITP) is an immune-mediated disorder resulting in platelet destruction and subsequent thrombocytopenia. Bleeding symptoms range from mild cutaneous bleeding to life-threatening hemorrhage. Romiplostim, a peptide-antibody fusion product, is a thrombopoietin receptor agonist (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Megan M, Grimes, Amanda B, Kim, Taylor Olmsted, Despotovic, Jenny M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383044/
https://www.ncbi.nlm.nih.gov/pubmed/32801654
http://dx.doi.org/10.2147/PPA.S192481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383044/
https://www.ncbi.nlm.nih.gov/pubmed/32801654
http://dx.doi.org/10.2147/PPA.S192481

Ejemplares similares